1999
DOI: 10.1002/(sici)1096-8628(19990129)82:3<242::aid-ajmg9>3.0.co;2-e
|View full text |Cite
|
Sign up to set email alerts
|

Lethal neonatal Hutchinson-Gilford progeria syndrome

Abstract: We report on a 35-week gestation female fetus with Hutchinson-Gilford progeria (HGP). This patient, who is the first reported with neonatal HGP in the English literature but is the fourth, counting three previous French cases, supports the existence of a more severe prenatal form of progeria. She died 7 hours after birth and presented with intrauterine growth retardation, premature aging, absence of subcutaneous fat, brachydactyly, absent nipples, hypoplastic external genitalia, and abnormal ear lobes. The chi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

1999
1999
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(21 citation statements)
references
References 17 publications
1
20
0
Order By: Relevance
“…This would be consistent with the recent observation that exclusive expression of farnesylatable progerin elicited a relatively more severe progeroid phenotypes than those of its non-farnesylated form in knock-in mice [37]. On the other hand, exclusively expressed non-farnesylated prelamin A still induced prominent cardiomyopathy but not progeria in knock-in mice, whereas the survival of such mice which exclusively produce farnesylatable prelamin A was very similar to that of wild-type mice [38], which is quite possibly due to the lower amount of farnesylated prelamin A. Embryonic senescence and further unforeseen developmental abnormalities may also be occurring in human (or mice) progeria given that severe neonatal lethality has been reported [15] [77] [78].…”
Section: Discussionmentioning
confidence: 98%
“…This would be consistent with the recent observation that exclusive expression of farnesylatable progerin elicited a relatively more severe progeroid phenotypes than those of its non-farnesylated form in knock-in mice [37]. On the other hand, exclusively expressed non-farnesylated prelamin A still induced prominent cardiomyopathy but not progeria in knock-in mice, whereas the survival of such mice which exclusively produce farnesylatable prelamin A was very similar to that of wild-type mice [38], which is quite possibly due to the lower amount of farnesylated prelamin A. Embryonic senescence and further unforeseen developmental abnormalities may also be occurring in human (or mice) progeria given that severe neonatal lethality has been reported [15] [77] [78].…”
Section: Discussionmentioning
confidence: 98%
“…Affected children appear normal at birth but then manifest a number of disease phenotypes, including failure-to-thrive, dental abnormalities, micrognathia, stiff joints, alopecia, sclerodermatous skin, loss of subcutaneous fat, osteoporosis, and osteolytic lesions in bones (3, 31, 36, 37, 40, 57, 82). Death generally occurs by the teenage years, generally from occlusions of the coronary or cerebral arteries.…”
Section: Lmna Mutations and Human Diseasementioning
confidence: 99%
“…Lamin A has also recently emerged as a key player vulnerable to epigenetic changes that contribute to aging [69-72]. Embryonic senescence and further unforeseen developmental abnormalities may also be occurring in human (or mice) progeria in either de novo genetic and/or epigenetic manners, given that severe neonatal lethality has been reported [73-75]. Thus, aging research should therefore extend to the study of early developmental process at least within the context of reproduction and regeneration.…”
Section: Evolutionary Developmental Origins Of Aging and Diseasementioning
confidence: 99%